These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1576941)

  • 21. Coronary risk factors and their possible causal role in the development of coronary heart disease: the Oslo study.
    Holme I
    J Oslo City Hosp; 1982; 32(7-8):80-105. PubMed ID: 7119924
    [No Abstract]   [Full Text] [Related]  

  • 22. Fletcher Challenge-University of Auckland Heart & Health Study: design and baseline findings.
    MacMahon S; Norton R; Jackson R; Mackie MJ; Cheng A; Vander Hoorn S; Milne A; McCulloch A
    N Z Med J; 1995 Dec; 108(1013):499-502. PubMed ID: 8532233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of multiple risk factors on coronary artery disease: beyond total cholesterol. Introduction.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):1Q-2Q. PubMed ID: 9819097
    [No Abstract]   [Full Text] [Related]  

  • 25. Thirty years of attempts to reduce coronary heart disease: new proposals.
    Nour-Eldin F
    Eur J Med; 1992 Oct; 1(6):358-61. PubMed ID: 1341464
    [No Abstract]   [Full Text] [Related]  

  • 26. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Coronary risk factors in high-rank athletes].
    De Miranda RF; Da Silva JA; Alves PM; De Rose EH; De Araújo CG
    Arq Bras Cardiol; 1991 Sep; 57(3):189-95. PubMed ID: 1824194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fibrinogen, a cardiovascular risk factor].
    Ferrara E; Cucchi G; Sardeo C
    Minerva Cardioangiol; 1989 Nov; 37(11):473-5. PubMed ID: 2622536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The functional state of platelets in kidney cancer].
    Goloshchapov ET
    Vopr Onkol; 1986; 32(4):43-6. PubMed ID: 3705527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of hemostatic markers in the pathogenesis of coronary diseases].
    Russo C
    Recenti Prog Med; 2002 Feb; 93(2):75-7. PubMed ID: 11887348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemostatic factors and coronary heart disease.
    Lancet; 1981 Jan; 1(8210):22-3. PubMed ID: 6109053
    [No Abstract]   [Full Text] [Related]  

  • 32. [Platelet-vascular, plasma hemostasis and transient myocardial ischemia].
    Zharov EI; Styrova TK; Vertkin AL; Martynov AI; Galichenko IV
    Kardiologiia; 1991 Aug; 31(8):86-90. PubMed ID: 1795487
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in the thrombocyte and procoagulant links in hemostasis in patients with arterial hypertension].
    Vasilenko AM; Kovalenko VN; Kuz'mina AP
    Lik Sprava; 1992 Aug; (8):65-6. PubMed ID: 1475931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group.
    Meade TW; Stirling Y; Thompson SG; Vickers MV; Woolf L; Ajdukiewicz AB; Stewart G; Davidson JF; Walker ID; Douglas AS
    Int J Epidemiol; 1986 Sep; 15(3):331-6. PubMed ID: 3095254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemostatic factors in coronary heart disease.
    Nordøy A
    J Intern Med; 1993 May; 233(5):377-83. PubMed ID: 8487003
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of CIBA 13,437-Su on serum cholesterol and triglycerides, plasma fibrinogen, fibrinolysis and platelet adhesiveness in patient with ischemic hert disease.
    Mannucci PM; Pareti F; Maggi CA; Diaguardi M
    Atherosclerosis; 1971; 13(1):1-8. PubMed ID: 4926863
    [No Abstract]   [Full Text] [Related]  

  • 37. Haemostatic factors and ischaemic heart disease. The Caerphilly study.
    Yarnell JW; Sweetnam PM; Elwood PC; Eastham R; Gilmour RA; O'Brien JR; Etherington MD
    Br Heart J; 1985 May; 53(5):483-7. PubMed ID: 3994861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FIBRINOLYSIS AND INTRINSIC HAEMOSTASIS.
    STAFFORD JL
    Br Med Bull; 1964 Sep; 20():179-84. PubMed ID: 14209756
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet hyperreactivity and inefficient spontaneous thrombolysis in patients at high risk from an acute coronary event.
    Peters NS; Abrams LS; Dymond DS; Kovacs IB
    Cardiovasc Res; 1989 Jul; 23(7):567-72. PubMed ID: 2598212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Whole blood- and plasma viscosity in the presence of coronary risk factors. Investigations concerning the characteristics of blood flow and viscosity-effective plasma components in patients with coronary risk factors and risk factor combinations (author's transl)].
    Leonhardt H; Uthoff A; Uthoff C
    Klin Wochenschr; 1977 May; 55(10):481-7. PubMed ID: 69049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.